CATS Consultants GmbH

 

Saarburgstrasse 31

D-82166 Gräfelfing

Tel: +49.89.85466868

Fax: +49.89.85852637

E-mail:     claudia@catsconsultants.com

               adriaan@catsconsultants.com

 

Geschäftsführer der CATS Consultants GmbH: Dr. Claudia Fruijtier-Pölloth und Adrianus Fruijtier

Registergericht: Amtsgericht München, Registernummer: HRB 152616

Umsatzsteuernummer-Identifikationsnummer gemäss § 27a Umsatzsteuergesetz: DE236214780

 

 

Home
Who we are
Previous projects
Presentations
Publications
Scientific Committees
Professional Societies
Our Fees
Contact us

CATS Consultants are regularly asked to speak at international conferences.

Regulatory Affairs

Please find below an overview of the topics we have covered in the past.

2008

  • Introduction to the EU Clinical Trial Directive 2001/20/EC, Clinical Trials Summer School, Informa Life Sciences, Cambridge, United Kingdom, September 2008

  • Outlining the key aspects of clinical trial guidelines and directives and introducing the regulators, Clinical Trials Summer School, Informa Life Sciences, Cambridge, United Kingdom, September 2008

  • European Regulatory Affairs Summer School, Conference Chairman and Speaker, Informa Life Sciences, Cambridge, United Kingdom, July 2008

  • Examining the regulatory perspective on adaptive clinical trials. Adaptive Designs for Clinical Development, Informa Life Sciences, London, United Kingdom, May 2008

2007

  • European Regulatory Affairs Summer School. Conference Chairman and Speaker, Informa Life Sciences, Oxford, United Kingdom, July 2007

2006

  • The FDA process for Scientific Advice. Scientific Advice 2006, IIR Conferences, London, United Kingdom, March 2006

2005

  • Regulatory Requirements in the EU and the US for Similar Biological Medicinal Products, Arbeitskreis Regulatorische Toxikologie, Martinsried, Germany, November 2005

  • Overview of new EU legislation, RAPS 2005 Annual Conference, RAPS, Baltimore, USA, October 2005

  • The Clinical Trials Directive, RAPS 2005 Annual Conference, RAPS, Baltimore, USA, October 2005

  • Post-Marketing. Principles & Practices of EU Regulatory Affairs, RAPS, Berlin, Germany, May 2005

  • Overview of Clinical Trials. Principles & Practices of EU Regulatory Affairs, RAPS, Berlin, Germany, May 2005

  • Marketing Authorization Process. Principles & Practices of EU Regulatory Affairs, RAPS, Berlin, Germany, May 2005

  • Manufacturing Requirements. Principles & Practices of EU Regulatory Affairs, RAPS, Berlin, Germany, May 2005

  • Guideline on the requirements to the chemical and pharmaceutical quality documentation concerning investigational medicinal products in clinical trials CHMP/QWP/185401/2004. Clinical Trials Directive, IIR Conferences, Paris, France, April 2005

  • One day pre-conference workshop: A review of the most recent updates of implementation texts and national guidelines. Clinical Trials Directive, IIR Conferences, Paris, France, April 2005

  • Two day course: Clinical Trials Directive, Pharmaceutical Training International, London, United Kingdom, April 2005

  • Type IA and Type IB Variations, Variations 2005, IIR Conferences, London, United Kingdom, March 2005

  • One day pre-conference workshop: Understanding Regulatory Affairs for generics, 4th Annual Global Generic Strategy Summit, IIR Conferences, Barcelona, Spain, March 2005

  • Two day course: Regulatory Affairs for Generics, Pharmaceutical Training International, London, United Kingdom, January 2005

  • Two day registration training: EU legislation review with an overview of upcoming changes and Type I & Type II variations, PTI and PTMS, Istanbul, Turkey, January 2005

2004

  • One day post-conference workshop: The Revised Directive Implementation Texts, The Clinical Trials Directive, IIR Conferences, London, United Kingdom, December 2004

  • Two day course: Regulatory Affairs for Central & Eastern Europe, Pharmaceutical Training International, London, United Kingdom, November 2004

  • SmPC Role and Issues, Challenges in Product Information (PI) - Is a Harmonised View Achievable?, Drug Information Association, Scheveningen, The Netherlands, October 2004

  • The evolving regulatory framework in an EU of 25 members, The Centralised and Mutual Recognition Procedures in an Enlarged EU, IIR Conferences, London, United Kingdom, September 2004

  • The ICH Process and the CTD Dossier, International Regulatory Affairs Summer School, IBC Life Sciences, Cambridge, United Kingdom, September 2004

  • Clinical trial applications in the EU and US, Clinical Trials Directive, IIR Conferences, London, United Kingdom, June 2004

  • Variations & Life Cycle Maintenance, Conference Chairman and Speaker, IIR Conferences, London, United Kingdom, May 2004

2003

  • Streamlining your regulatory procedures to successfully file product variations globally, Variations 2003, Amsterdam, The Netherlands, October 2003

2002

  • Implementing the CTD, Conference Chairman, IIR Conferences, Amsterdam, The Netherlands, December 2002

  • Filing eCTD Centralised applications – how will these be processed by the EMEA, Rapporteur, Co-rapporteur and the CPMP members?, The Electronic Common Technical Document and Electronic Submissions, IBC Life Sciences Conferences, London, United Kingdom, September 2002

  • e-Regulatory: Submission of electronic data and documents, PASG Spring Meeting, Meriden, United Kingdom, April 2002  

  • Considerations for running the Centralised Procedure, Centralised Procedure Training Meeting, AstraZeneca, Wedel, Germany, January 2002

2001

  • The current regulatory requirements for electronic submissions, Preparing for compulsory electronic submissions, Henry Stewart Conferences, London, United Kingdom, November 2001

  • Electronic Dossier Submissions: View from the Inside, BrAPP Annual Symposium, London, United Kingdom, July 2001

  • Electronic Submissions – What is there to know?, e-SOP’s in Clinical Research, Henry Stewart Conferences, London, United Kingdom, June 2001

2000

  • Operation of the Centralised Procedure during 2000 and changes for 2001, BIRA 2000 Annual Review Meeting, London, United Kingdom, December 2000

  • The Centralised Procedure and the role of the EMEA, IFB Regulatory Affairs Course, London, United Kingdom, November 2000

  • Regulatory Perspective, Product Information Management (PIM), EMEA Open Day, London, United Kingdom, September 2000

  • The EMEA: Role, Structure and Financial Operations, Presentation to the Chinese Health Authorities, Reading, United Kingdom, August 2000

  • Navigating the process, BIRA/ESRA meeting “Optimising your use of the centralised procedure”, London, United Kingdom, February 2000

 

[Home] [Who we are] [Previous Projects] [Presentations] [Publications] [Scientific Committees] [Professional Societies] [Our Fees] [Contact us]